Longevity Science

Berberine for Cholesterol: What the Trials Show and How Renew Uses It

3 min read
AL

Andrew Le, MD

Andrew founded Renew Health to change how cardiovascular disease is detected and treated.

In a 2025 meta-analysis of 12 placebo-controlled trials, berberine lowered LDL cholesterol by 0.495 mmol/L (about 19 mg/dL) and triglycerides by 0.367 mmol/L (about 33 mg/dL) compared with placebo. Renew uses berberine as one part of a measured plan, and we check your lipids before and after you start.

For how berberine compares with the other heart supplements, see our guide to supplements for cardiovascular health.

Three bars show how much lower each marker was with berberine than with placebo: LDL cholesterol 0.495 mmol/L, triglycerides 0.367 mmol/L and fasting glucose 0.515 mmol/L.
Created with BioRender.com (Industry).

When the question comes up

Your LDL went up again this year. Your doctor offered a statin and said to come back in twelve months. If you're weighing a supplement at that point, here's what the berberine data say.

What the trials show

A 2025 systematic review pooled 12 randomized, placebo-controlled trials of purified berberine. Compared with placebo, berberine lowered:

  • LDL cholesterol by 0.495 mmol/L (about 19 mg/dL), across 8 trials and 750 people
  • Triglycerides by 0.367 mmol/L (about 33 mg/dL)
  • Fasting glucose by 0.515 mmol/L (about 9 mg/dL)
  • Waist circumference by 3.27 cm

It didn't change HDL cholesterol or blood pressure. Side effects were no more common than with placebo. The LDL results varied widely from trial to trial (I² of 89%). Courses of 90 days or less showed larger LDL drops than longer ones. (Liu et al., Frontiers in Pharmacology, 2025, PMC12307485)

What the trials did not test

These trials measured blood markers and waist size over weeks to months. None of them measured heart attacks, strokes, or deaths. Berberine has no cardiovascular outcome data comparable to statins or metformin. We don't present it as a replacement for either.

How Renew uses berberine

Your Renew physician decides whether berberine fits. That call rests on your labs and the medicines you already take. We run your lipid panel, including ApoB, before you start and again at follow-up labs. You see whether your numbers moved. The plan changes with them.

Berberine also lowered fasting glucose in these trials. If your glucose is drifting up, our page on insulin resistance explains why that matters for your arteries. If your triglycerides stay high, prescription EPA has event data that berberine lacks. See our omega-3 review.

Sources

  • Liu D, et al. Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials. Frontiers in Pharmacology, 2025. PMC12307485

Next step

A CIMT scan shows the artery wall itself. Renew's scan is $389 one-time and includes clinician review. Book your CIMT.

Part of our Longevity Science guide

Ready to see your actual risk?

Advanced metabolic testing, arterial imaging, and a personalized prevention plan, built around your numbers.

View Memberships